Denied

No. 19-152

Amarin Pharma, Inc., et al. v. International Trade Commission, et al.

from the United States Court of Appeals for the Federal Circuit

See other cases from the Federal Circuit.

Docket Entries

Petition DENIED.

DISTRIBUTED for Conference of 12/6/2019.

Reply of petitioners Amarin Pharma, Inc., et al. filed.

Brief of respondents Royal DSM NV, et al. in opposition filed.

Brief of respondents International Trade Commission, et al. in opposition filed.

Letter of October 22, 2019 from counsel for petitioners filed.

Motion to extend the time to file a response is granted and the time is further extended to and including November 4, 2019, for all respondents.

Motion to extend the time to file a response from October 3, 2019 to November 4, 2019, submitted to The Clerk.

Motion to extend the time to file a response is granted and the time is extended to and including October 3, 2019, for all respondents.

Motion to extend the time to file a response from September 3, 2019 to October 3, 2019, submitted to The Clerk.

Motion of International Trade Commission, et al. for an extension of time not accepted for filing. (August 28, 2019 - Corrected motion to be filed)

Petition for a writ of certiorari filed. (Response due September 3, 2019)

Parties

Amarin Pharma, Inc., et al., Petitioner, represented by Ashley C. Parrish

International Trade Commission, et al., Respondent, represented by Noel J. Francisco

Royal DSM NV, DSM Marine Lipids Peru S.A.C., DSM Nutritional Products, LLC, DSM Nutritional Products Canada, Inc., Pharmavite LLC, Respondent, represented by Mark Simon Davies

Amici Curiae

Nordic Naturals, Inc. and Nordic Pharma, Inc., Amicus Curiae, represented by Andrew Fred Pratt

 
Last updated: December 12, 2024